Insight Briefs30 October 2025 Implications of Assessing Overall Survival in Oncology Studies The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in... Learn more
Insight Briefs30 September 2025 Automated Evidence Generation for Regulatory-Grade Real-World Data Manual data abstraction can’t keep up with new FDA and EMA RWE standards. This whitepaper explains how automated... Learn more
Insight Briefs25 September 2025 The EMR Interoperability Dream vs. Clinical Research RealityA Practical Guide to the 21st Century Cures Act, FHIR Data, and Bridging the Gap for Regulatory-Grade Evidence Discover the real-world challenges of EMR interoperability in clinical research. Learn how the 21st Century Cures Act, FHIR... Learn more
Insight Briefs18 September 2025 ICH GCP E6(R3) Implementation: Practical Approaches and Real-World Considerations ICH GCP E6(R3) implementation requires strategic planning beyond basic compliance. This practical guide covers realistic 12-18 month timelines,... Learn more